The largest database of trusted experimental protocols

Ni2 nta column

Manufactured by GE Healthcare
Sourced in United States

The Ni2+-NTA column is a type of affinity chromatography column used for the purification of histidine-tagged proteins. It utilizes the high affinity interaction between the nickel ions (Ni2+) immobilized on the column's resin and the histidine tags present on the target proteins, allowing for their selective capture and separation from a complex mixture.

Automatically generated - may contain errors

22 protocols using ni2 nta column

1

Purification and Crystallization of PBP2 Mutant

Check if the same lab product or an alternative is used in the 5 most similar protocols
The constructs encoding PBP2-6140CT with A501 mutations comprise residues 44–581 of PBP2 fused in-frame to the C-terminal end of His6-tagged maltose-binding protein (MBP) with an intervening tobacco etch virus (TEV) protease site. The protein was expressed at 18°C, the cells lysed, and the fusion protein was purified from the soluble fraction on a Ni2+-NTA column (GE Healthcare, Piscataway, NJ). The peak fractions were pooled and dialyzed at 4 °C at a 10:1 molar ratio of MBP-PBP2 to His6-TEV, which resulted in nearly complete digestion of the fusion protein. The mutant PBP2 variants were then rerun over a Ni2+-NTA column to remove His6-MBP, uncleaved fusion protein, and His6-TEV. The purified proteins were concentrated to ~20 mg ml−1 in 20 mM Tris•HCl, pH 8.0, 500 mM NaCl, 10% glycerol and stored at −80°C until ready for use.
Crystals of PBP2-6140CT-A501T were grown by vapor diffusion at 24°C in hanging drops, where the reservoir contained 2.2 M ammonium sulfate buffered with 100 mM Tris pH 8.25. Crystals were cryo-protected by passage through mother liquor to which glycerol had been added to a final concentration of 30% (v/v), followed by flash freezing in liquid nitrogen.
+ Open protocol
+ Expand
2

Recombinant Protein Purification from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following cultivation of E. coli BL21 Star (DE3) cells harboring the desired constructs, the induction and purification of target proteins were performed as described previously (14 (link)). The His-tagged target proteins were subjected to purification through a Ni2+-NTA column (GE Healthcare, Chicago, IL, USA). The fractions containing rEDIII-CaM and VP1 peptide-TrxA proteins were confirmed by 12% polyacrylamide gel containing 1% sodium dodecyl sulfate (12% SDS-PAGE). The rEDIII protein, which was expressed from pET21d-rEDIII (14 (link)), was produced and purified as described previously (14 (link), 25 (link)).
+ Open protocol
+ Expand
3

Recombinant Enzyme Purification and Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enzymes
were expressed in E. coliBL21 (DE3) cells (Takara, Dalian, China) using pET derived
plasmids. The recombinant cells were first grown in the LB medium
supplemented with 50 μg/mL kanamycin at 37 °C until the
OD600 reached 0.6 and gene expression was induced by adding 0.1 mM
isopropyl β-d-thiogalactopyranoside (IPTG) for an additional
18 h at 20 °C. The harvested cells were washed twice with 20
mM Tris-HCl buffer (pH 7.0) and suspended in a buffer of 50 mM Na2HPO4 (pH 7.0), 0.2 mM EDTA, and 0.1 mM dithiothreitol.
Suspended cells were disrupted by sonication and centrifuged at 100 000g for 1 h. The supernatant was purified using a Ni2+-NTA column (GE Healthcare Bio-Sciences, Piscataway, NJ) to obtain
samples for the activity assay. The purity of enzymes was checked
by SDS-PAGE (Bio-Rad Laboratories, Hercules) and the protein concentrations
were quantified using a Bradford protein assay kit (Bio-Rad Laboratories,
Hercules).
The in vitro activity of TD was
measured following the previous reports. The reaction of each activity
assay contained 20 μM PLP, 50 mM potassium phosphate buffer
(pH 7.5), 10 mM threonine, an appropriate amount of the enzyme, and
varied concentrations of isoleucine. The reaction was carried out
at 30 °C and the formation of α-ketobutyrate was measured
at 230 nm using a BioTek Microplate Reader. Each measurement has been
repeated three times.
+ Open protocol
+ Expand
4

Autophagy Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against LC3 I/II, p70S6 K, ULK, and beclin 1 were purchased from Cell Signaling Technology. Antibodies against GAPDH and His-Tag were purchased from Beyotime. Antibodies against TLR2 and TLR4 were purchased from Abcam. Antibody against p-mTOR was purchased from Santa Cruz. Protein-G coupled agarose beads and RapidStep™ ECL Reagent were purchased from Millipore. Ni2+-NTA column was purchased from GE lifesciences. DMEM High glucose culture medium was purchased from Hyclone. Cell lysis buffer for Western and IP and Nitric Oxide Synthase Assay Kit was purchased from Beyotime. Protease Inhibitor Cocktail is purchased from Bimake. Red Cell Lysis Buffer was purchase from Tiangen. Rapamycin and Bafilomycin A1 were purchased from Selleck. Clodronate Liposome was purchased from Liposoma.
+ Open protocol
+ Expand
5

Purification of SNARE Complex Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
syt1, cpx2, EIIAGlc, MSP1D1, and SNAREs were expressed in BL21 STARTM (DE3) and purified using GSTrap and Ni2+-NTA columns20 (link),25 (link),44 (link)–47 (link). To produce spMSP1D1,spNW15, spNW25, spNW30, spNW50, spNW80, and spNW100, plasmids were transformed into BL21 STARTM (DE3) cells that were grown in LB supplemented with Km (50 mg/ml) to OD600 ~ 0.7. Protein expression was induced with 0.2 mM IPTG at 16 °C overnight. Bacteria were harvested by centrifugation at 3450 × g for 20 min, resuspended in buffer A (50 mM Tris-HCl (pH 8),100 mM NaCl, 5% glycerol, 2 mM β-mercaptoethanol), and lysed on ice using a Branson cell disrupter (60% duty cycle, 45 secs). Cell lysates were clarified by centrifugation at 12,000 × g for 45 mins. The supernatants were loaded onto a 1 ml Ni2+-NTA column (GE Healthcare), followed by extensive wash (20 column volume) using buffer B (50 mM Tris-HCl (pH 8), 20 mM Imidazole, 400 mM NaCl, 5% glycerol, 2 mM β-mercaptoethanol). Proteins were eluted in buffer C (50 mM Tris-HCl (pH 8), 500 mM Imidazole, 400 mM NaCl, 5% glycerol, 2 mM β-mercaptoethanol), desalted in buffer A using PD MiDiTrap G-25 (GE Healthcare), and stored at −80 °C.
+ Open protocol
+ Expand
6

Cloning and Purification of RdAcuH and PrpE

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RdacuH gene was amplified from the genome of Roseovarius nubinhibens ISM by PCR using FastPfu DNA polymerase. PCR primers were designed with the NdeI and XhoI restriction sites. The amplified RdacuH is recombined to the vector pET-22b. FastPfu DNA polymerase and the vector pET-22b were purchased from TransGen Biotech (China) and Novagen company (Germany), respectively.
All site-directed mutations were introduced using overlap PCR and verified by sequencing. The constructed recombinant plasmids, including the wild type RdacuH and its mutants were transferred into E. coli BL21 (DE3) for expression. The cells were cultured in LB medium with 0.1 mg/ml ampicillin at 37°C to an OD600 of 1.0-1.2. Then the culture was induced at 20°C overnight with 0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG). Wild type RdAcuH and its mutants were purified by affinity chromatography on a Ni2+-NTA column (GE healthcare, United States), and then fractionated by anion exchange chromatography on a Source 15Q column (GE healthcare, United States) and gel filtration on a Superdex G200 column (GE healthcare, United States).
The prpE gene was amplified from the genomic DNA of Dinoroseobacter shibae DFL 12. Expression and purification of PrpE were conducted with the same methods as RdAcuH described above.
+ Open protocol
+ Expand
7

Expression and Purification of Tle1 and VgrG/Hcp

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primers were designed according to the sequences of the tle1AH and vgrG genes of A. hydrophila NJ-35 in GenBank (accession number NZ_CP006870). Tle1AH was cloned into the pGEX-4T-1 vector (Invitrogen) for expression with an N-terminal glutathione-S-transferase (GST) tag. VgrG/hcp was cloned into the pET-28a vector (Invitrogen) with a His tag. The GST-Tle1AH and His-VgrG/Hcp proteins were expressed in BL21 (DE3) cells (CWBIO, Beijing, China). The transformed cells were cultured in LB medium at 37 °C to an OD600 of 0.8, at which time the fusion protein expression was at the highest level and most was expressed as soluble protein not as an inclusion body based on our preliminary experiment. Protein expression was induced with 100 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) at 16 °C for 20 h. The cultures were harvested by centrifugation at 8000 × g, resuspended in 1 × PBS and lysed by sonication. The lysate was centrifuged at 12 000 × g for 15 min at 4 °C to remove precipitate, and then the supernatant was loaded on a Ni2+-NTA column (GE Healthcare, Shanghai, China) to purify the proteins. The eluted proteins were collected and dialyzed for pull-down assays.
+ Open protocol
+ Expand
8

Recombinant Basigin Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
A section of the basigin gene encoding immunoglobin domains 1 and 2 of the short isoform (residues 22-205) was amplified from cDNA using primers: 5′-CCGGATCCGCTGCCGGAACCGTGTTC-3′ and CCCATATGCTAGTGTGACCGCACTCTCAGG-3′. PCR products were cloned into a modified pET15b vector (Novagen), which encodes an N-terminal hexa-histidine tag followed by a tobacco etch virus (TEV) protease cleavage site. TEV cleavage leaves an additional glycine at the N-terminus from the cleavage site.
Basigin was expressed in bacterial strain Origami B (DE3) (Novagen) by incubation overnight at 25°C after induction with 1mM IPTG. The protein was purified by nickel-nitrilotriacetic acid (Ni2+-NTA; Qiagen) affinity chromatography, followed by buffer exchange into PBS using a PD-10 desalting column (GE Healthcare), and overnight cleavage with His-tagged TEV protease at 4°C, before a second Ni2+-NTA column. The flow-through was concentrated using an Amicon Ultra centrifugal filter device (molecular mass cutoff, 3,000 Da). Finally, gel filtration was performed with a Superdex 200 16/60 column (GE Healthcare) in 20 mM HEPES (pH 7.5) and 150 mM NaCl.
+ Open protocol
+ Expand
9

E. coli Expression and Purification of DARPin9_29-HSP70

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly transformed E. coli BL21 (DE3) cells were grown in SOB medium containing 0.1 g/L ampicillin; the lac-promoter was induced with 1 mM ITPG at OD600 of 0.7. Expression was allowed to continue for 12 h at 37 °C. Cells were harvested by centrifugation at 6000× g for 15 min at 4 °C, and the cell pellet was resuspended in lysis buffer (20 mM Tris-base, 20 mM NaCl, 20 mM MgCl2, and 1 mg/mL lysozyme). The suspension was incubated for 30 min at room temperature and then sonicated on ice. Cellular debris was removed by centrifugation at 15,000× g for 30 min at 4 °C.
The solution was applied to a Ni2+-NTA column (GE Healthcare) equilibrated in 100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, and pH 8.0 buffer (B1). DARPin9_29-HSP70 was eluted with pH 4.5 B1 buffer. The protein yield was 10 mg/L of growth medium.
+ Open protocol
+ Expand
10

Cloning and Purification of SBPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genes encoding SBPs from R. pomeroyi DSS-3 or R. nubinhibens ISM were amplified from the genome of R. pomeroyi DSS-3 or R. nubinhibens ISM by PCR using FastPfu DNA polymerase (TransGen Biotech, China). The dmpX homologue from P. sp. strain HTCC7211 (locus tag HTCC7211_00013840) was synthesized by the Beijing Genomics Institute (China). The related genes were then cloned into the NdeI/XhoI restriction sites of the pET-22b vector (Novagen, Germany) with a C-terminal His tag. Point mutations in DmpX were introduced using the PCR-based method and verified by DNA sequencing. The SBPs and corresponding mutant forms were produced in E. coli BL21 (DE3). The cells were cultured in the LB medium with 0.1 mg/ml ampicillin at 37 °C to an OD600 of 0.8–1.0 and then induced at 18 °C for 16 h with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG). After induction, cells were collected by centrifugation, resuspended in the lysis buffer (50 mM Tris-HCl, 100 mM NaCl, 0.5% glycerol, pH 8.0), and lysed by a pressure crusher. The proteins were first purified by affinity chromatography on a Ni2+-NTA column (GE Healthcare, US), and then fractionated by gel filtration on a Superdex G75 column (GE healthcare, US).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!